Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Interventional, Repeated Measures Feasibility Study to Evaluate Change in Tinnitus Severity for Adult Recipients of a Totally Implantable Cochlear Implant System Who Experience Tinnitus Pre-Operatively

NCT07893860 is registered in ClinicalTrials.gov with Cochlear as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07893860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Interventional, Repeated Measures Feasibility Study to Evaluate Change in Tinnitus Severity for Adult Recipients of a Totally Implantable Cochlear Implant System Who Experience Tinnitus Pre-Operatively
Lead sponsor
Cochlear
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 28, 2027
Completion date
April 30, 2028
Enrollment
14 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sensorineural hearing loss, tinnitus

Arms

As registered; 1 arm.

  • Totally Implantable Cochlear Implant System ExperimentalCochlear implant

    Participants will be implanted with the TI1132 implant

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Evaluate the impact of the TICI G2 Clinical Investigation System usage on Tinnitus Handicap Inventory (THI) ratings Preoperative baseline to 6- months post-activation

    Mean within-subject change in THI score. The THI measures tinnitus severity. The score ranges from Slight or No handicap (Grade 1): 0-16, Mild (Grade 2): 18-36, Moderate (Grade 3): 38-56, Severe (Grade 4): 58-76 to Catastrophic (Grade 5): 78-100

Lead sponsor's other trials

Cochlear, most recent start first.

Similar trials

Same condition (Tinnitus) and phase, most recent start first.